See what you’ve been missing.
From the live animal,
CRi’s award-winning Maestro™ and new Maestro™ 2
In Vivo Imaging Systems and Nuance™ 2 multispectral
imaging systems provide better sensitivity by delivering
improved Signal-to-Noise Ratios (elimination of tissue
autofluorescence).
True multiplexing of your fluorophores or brightfield stains
is enabled from Macro to Micro!
Maestro Multiplexed Image
Achieve quicker, more accurate pre-clinical and
Maestro 2 In Vivo Imaging System immunohistochemical results with systems specifically
designed to enable quantitative multiplexing.
to tissue under your microscope.
Let us show you how our
breakthroughs can enable yours.
The CRi Maestro™ imaging system has many applications involving a variety of materials, such as probes,
cell lines, animal specimens, etc. Certain of these applications and/or materials may require licensing under
Nuance Multiplexed Image
patents held by third parties. For example, a license from AntiCancer Incorporated, 7917 Ostrow St., San Diego,
CA 92111 and/or Caliper Life Sciences, Inc., 68 Elm St., Hopkinton, MA 01748, may be required for certain
Nuance 2 Multispectral Imaging System for applications and/or materials. CRi’s sale or other transfer of the Maestro™ imaging system does not convey
fluorescence or brightfield
any right or license under such third party patents. It is suggested, therefore, that users of the Maestro™
imaging system consult with counsel to determine whether licensing of such third party patents is required.
Seeing life in a new light.
Learn more about Maestro 2 & Nuance 2 by calling US Toll-Free 1-800-383-7924
or by visiting
www.cri-inc.com/maestro2 and
www.cri-inc.com/nuance2.
CRI_See_From.indd 1 10/15/07 11:02:35 AM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76